Literature DB >> 16312887

[Clinical observation on acupuncture combined with medication for intractable angina pectoris].

Feng-hua Xu1, Jian-ming Wang.   

Abstract

OBJECTIVE: To compare clinical effects of acupuncture combined with medication and simple medication on intractable angina pectoris (IAP).
METHODS: Seventy cases of IAP were randomly divided into two groups, a control group and a treatment group, 35 cases in each group. The control group were treated with nitric acid ester, beta-receptor blocking agent, calcium antagonist, aspirin and hypo-molecular heparin, and the treatment group were treated with acupuncture at Danzhong (CV 17) and Neiguan (PC 6) and others, once daily for 10 consecutive days on the basis of the above treatment.
RESULTS: The total effective rates for symptoms and electrocardiogram were 88.6% and 62.9% in the treatment group and 60.0% and 31.4% in the control group, respectively, with a significant difference between the two groups; the incidence of acute heart attack and sudden death of 5.7% in the treatment group was lower than 20.0% in the control group, with no serious adverse effect.
CONCLUSION: Acupuncture combined with medication is safe and effective for intractable angina pectoris and it can improve short-term prognosis.

Entities:  

Mesh:

Year:  2005        PMID: 16312887

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  9 in total

Review 1.  Acupuncture safety in patients receiving anticoagulants: a systematic review.

Authors:  Michael Mcculloch; Arian Nachat; Jonathan Schwartz; Vicki Casella-Gordon; Joseph Cook
Journal:  Perm J       Date:  2014-11-24

2.  Meta-analysis of acupuncture therapy for the treatment of stable angina pectoris.

Authors:  Ze Zhang; Min Chen; Li Zhang; Zhe Zhang; Wensheng Wu; Jun Liu; Jun Yan; Guanlin Yang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  Electroacupuncture Improves Choroidal Blood Flow to Inhibit the Development of Lens-Induced Myopia in Guinea Pigs.

Authors:  Ting Yu; Xiaofeng Xie; Huixia Wei; Qiuxin Wu; Xiuyan Zhang; Qingmei Tian; Jike Song; Hongsheng Bi
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-24       Impact factor: 2.650

4.  Effects of electroacupuncture on cardiac and gastric activities in acute myocardial ischemia rats.

Authors:  Shu-Bin Wang; Shu-Ping Chen; Yong-Hui Gao; Ming-Fu Luo; Jun-Ling Liu
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

5.  A protocol of histone modification-based mechanistic study of acupuncture in patients with stable angina pectoris.

Authors:  Ning Wang; Sheng-Feng Lu; Hui Chen; Jian-Fei Wang; Shu-Ping Fu; Chen-Jun Hu; Yi Yang; Fan-Rong Liang; Bing-Mei Zhu
Journal:  BMC Complement Altern Med       Date:  2015-04-30       Impact factor: 3.659

6.  Nicorandil effects on platelet function, Hs-CRP, MMP-9 and myocardial antioxidation in patients with unstable angina.

Authors:  Ruijun Peng; Xili Yang; Xi Liang
Journal:  Exp Ther Med       Date:  2019-08-20       Impact factor: 2.447

7.  Acupuncture for chronic, stable angina pectoris and an investigation of the characteristics of acupoint specificity: study protocol for a multicenter randomized controlled trial.

Authors:  Dehua Li; Mingxiao Yang; Ling Zhao; Hui Zheng; Ying Li; Xiaorong Chang; Jin Cui; Ruihui Wang; Jing Shi; Junling Lv; Junyan Leng; Juan Li; Fanrong Liang
Journal:  Trials       Date:  2014-02-05       Impact factor: 2.279

8.  Acupuncture promotes angiogenesis after myocardial ischemia through H3K9 acetylation regulation at VEGF gene.

Authors:  Shu-Ping Fu; Su-Yun He; Bin Xu; Chen-Jun Hu; Sheng-Feng Lu; Wei-Xing Shen; Yan Huang; Hao Hong; Qian Li; Ning Wang; Xuan-Liang Liu; Fanrong Liang; Bing-Mei Zhu
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

9.  Cardioprotective Effect of Electroacupuncture Pretreatment on Myocardial Ischemia/Reperfusion Injury via Antiapoptotic Signaling.

Authors:  Sheng-Feng Lu; Yan Huang; Ning Wang; Wei-Xing Shen; Shu-Ping Fu; Qian Li; Mei-Ling Yu; Wan-Xin Liu; Xia Chen; Xin-Yue Jing; Bing-Mei Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-25       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.